VivoSeq
Other

Nebulization

0

Pipeline Programs↗

0

Active Trials↗

0

Companies Involved↗

Nebulization is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

9

clinical trials

Completed7 · 78%
Unknown status2 · 22%

Clinical Trials

Trial Activity

9 trials

Surfactant Nebulization for the Early Aeration of the Preterm Lung
Completed·UUniversity of Zurich·Phase 3·NCT04315636·32 enrolled
Pain Relief by Intra-Peritoneal Nebulization of Ropivacaine Under Remifentanil Anesthesia for Gynecological Laparoscopy
Completed·—·Phase 3·NCT00927979·40 enrolled
Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session
Completed·CCliniques universitaires Saint-Luc- Université Catholique de Louvain·N/A·NCT02201082·15 enrolled
Streptokinase Versus Unfractionated Heparin Nebulization in Severe ARDS
Completed·—·Phase 3·NCT03465085·60 enrolled
Effects and Safety of Budesonide Inhalation Suspension Via Transnasal Nebulization in Nasal Polyps
Completed·—·Phase 2/3·NCT02024659·57 enrolled
Beta Agonist Nebulization in Non Invasively Ventilated COPD Patients: Safety, and Therapeutic Efficacy Range.
Completed·UUniversity Hospital, Tours·Phase 2·NCT01958814·43 enrolled
Ketamine Versus Lidocaine Nebulization for Awake Fiberoptic Intubation
Completed·—·Phase 4·NCT03414879·60 enrolled
Evaluation of Nebulization and Positive Expiratory Pressure Combination
Unknown status·CCliniques universitaires Saint-Luc- Université Catholique de Louvain·N/A·NCT02535130·15 enrolled
Normal Saline Nebulization on Prevention of Extubation Failure in Neonates
Unknown status·—·N/A·NCT05194761·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)